Plea For More Grants Dissolves Unity Of Joint Effort To Boost NIH Budget

WASHINGTON -- The unity of a coalition that each year campaigns for a large increase in the NIH budget has been splintered by a group of bench scientists who say the agency should fund more grants to individual investigators. The disagreement reflects the growing strain on the scientific community from declining funding rates for such grants and the perception of some scientists that their work is being squeezed out by megaprojects like the war against AIDS and the effort to map and sequence t

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON -- The unity of a coalition that each year campaigns for a large increase in the NIH budget has been splintered by a group of bench scientists who say the agency should fund more grants to individual investigators.

The disagreement reflects the growing strain on the scientific community from declining funding rates for such grants and the perception of some scientists that their work is being squeezed out by megaprojects like the war against AIDS and the effort to map and sequence the human genome.

Last month the 8,000-member American Society of Biochemists and Molecular Biologists (ASBMB) joined with the 6,500-member American Society of Cell Biology to hire Washington lobbyist Peter Kyros. His assignment is to persuade Congress to spend $200 million more than the Bush administration has requested for National Institutes of Health grants to individuals. That extra money would boost from 5,100 to 6,100 the number of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies